INGN - Inogen, Inc.
NEXT EARNINGS:
May 5, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.00
DETAILS
HIGH:
$26.00
LOW:
$26.00
MEDIAN:
$26.00
CONSENSUS:
$26.00
UPSIDE:
345.21%
Market Cap:
158.55M
Volume:
197,052
Avg Volume:
194,585
52 Week Range:
5.48-11.94
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.79
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
766
IPO Date:
2014-02-14
EPS (TTM):
-1.52
P/E Ratio:
-8.03
Revenue (TTM):
335.70M
Total Assets:
296.19M
Total Debt:
19.41M
Cash & Equiv:
113.80M
Rev Growth (5Y):
-1.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-19.4%
Debt/Equity:
0.11
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.20 | $-0.22 | +9.1% | $92.4M | $88.6M | +4.3% |
| 2025-08-07 | $-0.15 | $-0.22 | +31.8% | $92.3M | $93.3M | -1.1% |
| 2025-05-07 | $-0.25 | $-0.52 | +51.9% | $82.3M | $92.7M | -11.3% |
| 2025-02-25 | $-0.41 | $-0.56 | +26.8% | $80.1M | $73.9M | +8.4% |
| 2024-11-07 | $-0.25 | $-0.49 | +49.0% | $88.8M | $73.9M | +20.2% |
| 2024-08-06 | $-0.24 | $-0.55 | +56.4% | $88.8M | $82.5M | +7.6% |
| 2024-05-07 | $-0.62 | $-0.76 | +18.4% | $78.0M | $73.7M | +5.9% |
| 2024-02-27 | $-1.14 | $-0.62 | -83.9% | $75.9M | $77.0M | -1.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 335.70M | 315.66M | 377.24M | 358.00M | 308.49M | 361.94M | 358.11M | 249.44M | 202.83M | 159.00M | 112.54M | 75.44M |
| Net Income | (35.89M) | (102.45M) | (83.77M) | (6.33M) | (5.83M) | 20.95M | 51.84M | 21.00M | 20.52M | 11.59M | 6.83M | 25.43M |
| EPS | -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.96 | 2.30 | 1.02 | 1.02 | 0.60 | 0.33 | 1.01 |
| Total Assets | 296.19M | 326.19M | 405.04M | 489.51M | 461.85M | 447.34M | 375.90M | 275.07M | 214.05M | 161.31M | 140.09M | 82.40M |
| Total Debt | 19.41M | 21.92M | 23.28M | 26.67M | 10.01M | 6.72M | 0 | 0 | 0 | 315,000 | 614,000 | 10.65M |
| Cash & Equivalents | 113.80M | 125.49M | 187.01M | 235.52M | 211.96M | 198.04M | 196.63M | 142.95M | 92.85M | 66.11M | 56.84M | 13.52M |
| Operating Cash Flow | 5.91M | (3.23M) | (37.53M) | 23.63M | 37.01M | 40.59M | 59.98M | 60.49M | 31.03M | 38.16M | 15.70M | 13.47M |
| Free Cash Flow | (11.18M) | (29.75M) | (58.75M) | (302,000) | 19.67M | 34.08M | 47.00M | 50.27M | 23.02M | 25.67M | (540,000) | (4.67M) |
| FCF per Share | -0.47 | -1.28 | -2.57 | -0.01 | 0.89 | 1.56 | 2.09 | 2.43 | 1.15 | 1.32 | -0.03 | -0.26 |
| Book Value | 173.86M | 204.81M | 297.41M | 370.23M | 349.62M | 344.62M | 310.42M | 227.04M | 182.09M | 134.02M | 118.15M | 56.30M |
| Cash & ST Investments | 113.80M | 128.47M | 187.01M | 245.51M | 231.22M | 209.09M | 240.35M | 173.94M | 113.88M | 82.90M | 56.84M | 13.52M |
| ROC Equity | -0.21 | -0.50 | -0.28 | -0.02 | -0.02 | 0.06 | 0.17 | 0.09 | 0.11 | 0.09 | 0.06 | 0.45 |